A
Andrew V. Thillainayagam
Researcher at Imperial College London
Publications - 40
Citations - 2654
Andrew V. Thillainayagam is an academic researcher from Imperial College London. The author has contributed to research in topics: Fluorescence-lifetime imaging microscopy & Hepatocellular carcinoma. The author has an hindex of 21, co-authored 40 publications receiving 2434 citations. Previous affiliations of Andrew V. Thillainayagam include Northwick Park Hospital & Imperial College Healthcare.
Papers
More filters
Journal ArticleDOI
Guidelines for the diagnosis and treatment of cholangiocarcinoma: an update
Shahid A. Khan,Brian R. Davidson,Robert D. Goldin,Nigel Heaton,John Karani,Stephen P. Pereira,William Rosenberg,Paul Tait,Simon D. Taylor-Robinson,Andrew V. Thillainayagam,Howard C. Thomas,Harpreet Wasan +11 more
TL;DR: The British Society of Gastroenterology guidelines on the management of cholangiocarcinoma are updated based on a comprehensive review of the recent literature, including data from randomised controlled trials, systematic reviews, meta-analyses, cohort, prospective and retrospective studies.
Journal ArticleDOI
Guidelines for the diagnosis and treatment of cholangiocarcinoma: consensus document
Shahid A. Khan,Brian R. Davidson,Robert D. Goldin,Stephen P. Pereira,William Rosenberg,Simon D. Taylor-Robinson,Andrew V. Thillainayagam,H.C. Thomas,Mark Thursz,Harpreet Wasan +9 more
TL;DR: These guidelines are intended to bring consistency and improvement in the patient’s management from first suspicion of cholangiocarcinoma through to confirmation of the diagnosis and subsequent management, and are subject to change in light of future advances in scientific knowledge.
Journal ArticleDOI
Autologous infusion of expanded mobilized adult bone marrow-derived CD34+ cells into patients with alcoholic liver cirrhosis.
Madhava Pai,Dimitris Zacharoulis,Miroslav Milicevic,Salah Helmy,Long R. Jiao,Nataša Levičar,Paul Tait,Michael S. Scott,Stephen B. Marley,Kevin Jestice,Maria Glibetic,Devinder S. Bansi,Shahid A. Khan,Despina Kyriakou,Christos Rountas,Andrew V. Thillainayagam,Joanna Nicholls,Steen Lindkaer Jensen,Jane F. Apperley,Myrtle Y. Gordon,Nagy A. Habib +20 more
TL;DR: It is safe to mobilize, expand, and reinfuse autologous CD34+ cells in patients with ALC and the clinical and biochemical improvement in the study group is encouraging and warrants further clinical trials.
Journal ArticleDOI
A Randomized, Open-Label, Non-Inferiority Study of Intravenous Iron Isomaltoside 1,000 (Monofer) Compared With Oral Iron for Treatment of Anemia in IBD (PROCEED)
Walter Reinisch,Michael Staun,Rakesh K. Tandon,István Altorjay,Andrew V. Thillainayagam,C. Gratzer,Sandeep Nijhawan,Lars L. Thomsen +7 more
TL;DR: It is suggested that the true iron demand of IV iron was underestimated by the Ganzoni formula, and there was a trend for oral iron sulfate being more effective in increasing Hb than iron isomaltoside 1,000.
Journal ArticleDOI
Imaging of liver cancer
Ben Ariff,Claire R Lloyd,Sameer Khan,Mohamed I.F. Shariff,Andrew V. Thillainayagam,Devinder S. Bansi,Shahid A. Khan,Simon D. Taylor-Robinson,Adrian Lim +8 more
TL;DR: This review discusses the application of several imaging techniques in the diagnosis and staging of both hepatocellular carcinoma and cholangiocarcinoma and outlines certain characteristics of benign liver lesions.